References
- Gerritsen J, Dekker JM, Ten Voorde BJ, Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 2001; 24:1793–1798.
- Perin PC, Maule S, Quadri R. Sympathetic nervous system, diabetes, and hypertension. Clin Exp Hypertens 2001; 23:45–55.
- Tesfaye S, Stevens LK, Stephenson JM, Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996; 39:1377–1384.
- Tesfaye S, Chaturvedi N, Eaton SE, Vascular risk factors and diabetic neuropathy. N Engl J Med 2005; 352:341–350.
- Zarrelli MM, Amoruso L, Beghi E, Apollo F, Di Viesti P, Simone P. Arterial hypertension as a risk factor for chronic symmetric polyneuropathy. J Epidemiol Biostat 2001; 6:409–413.
- Cho DY, Mold JW, Roberts M. Further investigation of the negative association between hypertension and peripheral neuropathy in the elderly: an Oklahoma Physicians Resource/Research Network (OKPRN) Study. J Am Board Fam Med 2006; 19:240–250.
- Mold JW, Vesely SK, Keyl BA, Schenk JB, Roberts M. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older subjects. J Am Board Fam Pract 2004; 17:309–318.
- Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med 1980; 49:95–108.
- Masson EA, Veves A, Fernando D, Boulton AJ. Current perception thresholds: a new, quick and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus. Diabetologia 1989; 32:724–728.
- Pitei DL, Watkins PJ, Stevens MJ, Edmonds ME. The value of the Neurometer in assessing diabetic neuropathy by measurement of the current perception threshold. Diabet Med 1994; 11:872–876.
- Varkonyi TT, Borcso E, Toth F, Severity of autonomic and sensory neuropathy and the impairment of visual- and auditory-evoked potentials in type 1 diabetes: is there a relationship? Diabetes Care 2006; 29:2325–2326.
- Ziegler D. Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev 1994; 10:339–383.
- Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death: experimental basis and clinical observations for post myocardial infarction risk stratification. Circulation 1992; 85(Suppl.):177.
- Kempler P, Kerenyi Z, Tamas G. Autonomic neuropathy: comparison of two screening procedures. Diabetologia 1994; 37:1168–1169.
- Sowers JD, Epstein M, Frohlich ED. Diabetes, hypertension and cardiovascular disease: an update. Hypertension 2001; 37:1053–1059.
- Tuomilehto J, Rastenyte D, Birkenhager WH, Effects of calcium channel blockers in older patients with diabetes and systolic hypertension. N Engl Med J 1999; 340:677–684.
- Gasowski J, Birkenhager WH, Staessen JA, de Leeuw PW. Benefit of antihypertensive treatment in the diabetic patients enrolled in the Systolic Hypertension in Europe (Syst-Eur) trial. Cardiovasc Drugs Ther 2000; 14:49–53.